Royalty Pharma plc (RPRX) Operating cash flow 2018–2025
Royalty Pharma plc (RPRX) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
$2.5BFY2025 · since FY2018: $1.6B → $2.5B
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $2.5B | -10.1% |
| FY2024 | $2.8B | -7.3% |
| FY2023 | $3.0B | +39.4% |
| FY2022 | $2.1B | +6.3% |
| FY2021 | $2.0B | -0.8% |
| FY2020 | $2.0B | +22.0% |
| FY2019 | $1.7B | +3.0% |
| FY2018 | $1.6B | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More RPRX financial trends
RPRX RevenueRPRX Net incomeRPRX Net marginRPRX Gross profitRPRX Gross marginRPRX Operating incomeRPRX Operating marginRPRX Free cash flowRPRX Capital expendituresRPRX Return on equityRPRX Stock buybacksRPRX Dividends paidRPRX Total assetsRPRX Total liabilitiesRPRX Shareholders’ equityRPRX overview →